Skip to main content
Earnings Labs
Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc. (GALT) Earnings

NASDAQ·Healthcare·Biotechnology

$3.50

+3.24%

Mkt Cap $228.52M

EPS — Estimate vs Actual

Mkt Cap

$228.52M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$0.48